Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.85)
# 73
Out of 5,113 analysts
32
Total ratings
70.97%
Success rate
57.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ERAS Erasca | Maintains: Buy | $6 → $11 | $9.96 | +10.44% | 1 | Jan 13, 2026 | |
| STRO Sutro Biopharma | Maintains: Neutral | $2 → $10 | $15.05 | -33.55% | 1 | Dec 22, 2025 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $10 → $4 | $0.67 | +492.94% | 1 | Dec 19, 2025 | |
| TERN Terns Pharmaceuticals | Maintains: Buy | $20 → $60 | $34.33 | +74.77% | 2 | Dec 9, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $6.19 | +271.57% | 2 | Dec 3, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $25 | $11.95 | +109.21% | 1 | Nov 24, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $10 → $7 | $1.14 | +514.04% | 1 | Nov 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $40 | $20.25 | +97.53% | 2 | Oct 27, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $40 | $8.73 | +358.19% | 2 | Oct 20, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $23 | $6.20 | +270.97% | 1 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $105 | $75.03 | +39.95% | 2 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $44.29 | -0.65% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $53.81 | +39.38% | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $12.17 | +105.42% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $6.45 | +24.03% | 7 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.68 | +287.32% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $19.19 | +4.22% | 1 | Aug 8, 2025 |
Erasca
Jan 13, 2026
Maintains: Buy
Price Target: $6 → $11
Current: $9.96
Upside: +10.44%
Sutro Biopharma
Dec 22, 2025
Maintains: Neutral
Price Target: $2 → $10
Current: $15.05
Upside: -33.55%
Werewolf Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $10 → $4
Current: $0.67
Upside: +492.94%
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Buy
Price Target: $20 → $60
Current: $34.33
Upside: +74.77%
Protara Therapeutics
Dec 3, 2025
Reiterates: Buy
Price Target: $23
Current: $6.19
Upside: +271.57%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $25
Current: $11.95
Upside: +109.21%
TScan Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.14
Upside: +514.04%
Syndax Pharmaceuticals
Oct 27, 2025
Reiterates: Buy
Price Target: $40
Current: $20.25
Upside: +97.53%
Corbus Pharmaceuticals Holdings
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $8.73
Upside: +358.19%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $6.20
Upside: +270.97%
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $75.03
Upside: +39.95%
Sep 23, 2025
Maintains: Buy
Price Target: $50 → $44
Current: $44.29
Upside: -0.65%
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $53.81
Upside: +39.38%
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $12.17
Upside: +105.42%
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $6.45
Upside: +24.03%
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $5.68
Upside: +287.32%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $19.19
Upside: +4.22%